Neomycin and Polymyxin B Sulfates and Hydrocortisone Otic Suspension
Active substance: HYDROCORTISONE, NEOMYCIN SULFATE, POLYMYXIN B SULFATE
SUSPENSION · HYDROCORTISONE 10 mg/mL, NEOMYCIN SULFATE 3.5 mg/mL, POLYMYXIN B SULFATE 10000 [USP'U]/mL
United StatesActive
Marketing holder: Rising Pharma Holdings, Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
Composition
- HYDROCORTISONE · 10 mg/mL
- NEOMYCIN SULFATE · 3.5 mg/mL
- POLYMYXIN B SULFATE · 10000 [USP'U]/mL
Registration
- Registration number
- 64980-448
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- AURICULAR (OTIC)
Sources
- product · openFDA NDC · 64980-448 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 64980-448 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 64980-448 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 64980-448 · Verified 2026-10-09 · open in source
- ingredients.2 · openFDA NDC · 64980-448 · Verified 2026-10-09 · open in source